Therapeutic Areas

Bach Pharma is targeting serious and life threatening diseases in which oxidative stress plays a role. This includes neuroimmuno-degenerative illnesses like ALS.

BACH is working with the Department of Defense and the Veterans Administration to evaluate cognitive dysfunction and other symptoms seen in some veterans.

The broad activity seen preclinically with GVT® and in trials with this class of drug offers great promise to patients with a number of serious illnesses.